Sucralfate oral suspension 1 g/10mL
sucralfate · SUSPENSION · Glenmark Pharmaceuticals Inc., USA
Sucralfate oral suspension is a suspension containing sucralfate at 1 g/10mL, taken oral. Manufactured by Glenmark Pharmaceuticals Inc., USA.
Key Facts
- Brand Name
- Sucralfate oral suspension
- Generic Name
- sucralfate
- NDC Code (Product)
68462-827- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Strength
- 1 g/10mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- ANDA212141
- Drug Class
- Aluminum Complex [EPC]
- Marketing Start
- 01/05/2026
Recall History
DASH Pharmaceuticals LLC
Labeling: Label Mix-Up
VistaPharm LLC
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
VistaPharm LLC
Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
INDICATIONS AND USAGE Sucralfate oral suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.
Dosage & Administration
DOSAGE AND ADMINISTRATION Active Duodenal Ulcer: The recommended adult oral dosage for duodenal ulcer is 1 gram (10 mL) four times per day. Sucralfate oral suspension should be administered on an empty stomach. Antacids may be prescribed as needed for relief of pain but should not be taken within one-half hour before or after sucralfate oral suspension. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Elderly: In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy (see PRECAUTIONS, Geriatric Use ). Call your doctor for medical advice about side effects. You may report side effects to Glenmark Pharmaceutical Inc., USA at 1 (888) 721-7115 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
Warnings
WARNINGS Fatal complications, including pulmonary and cerebral emboli have occurred with inappropriate intravenous administration of sucralfate oral suspension. Administer sucralfate oral suspension only by the oral route. Do not administer intravenously.
Contraindications
CONTRAINDICATIONS Sucralfate oral suspension is contraindicated for patients with known hypersensitivity reactions to the active substance or to any of the excipients.
Adverse Reactions
ADVERSE REACTIONS Adverse reactions to sucralfate tablets in clinical trials were minor and only rarely led to discontinuation of the drug. In studies involving over 2,700 patients treated with sucralfate, adverse effects were reported in 129 (4.7%). Constipation was the most frequent complaint (2%). Other adverse effects reported in less than 0.5% of the patients are listed below by body system: Gastrointestinal: diarrhea, dry mouth, flatulence, gastric discomfort, indigestion, nausea, vomiting Dermatological: pruritus, rash Nervous System: dizziness, insomnia, sleepiness, vertigo Other: back pain, headache Post-marketing cases of hypersensitivity have been reported with the use of sucralfate oral suspension, including anaphylactic reactions, dyspnea, lip swelling, edema of the mouth, pharyngeal edema, pruritus, rash, swelling of the face and urticaria. Cases of bronchospasm, laryngeal edema and respiratory tract edema have been reported with an unknown oral formulation of sucralfate. Cases of hyperglycemia have been reported with sucralfate. Bezoars have been reported in patients treated with sucralfate. The majority of patients had underlying medical conditions that may predispo…
Frequently Asked Questions
What is Sucralfate oral suspension used for?
Sucralfate oral suspension contains sucralfate. It is a suspension taken oral. Consult your doctor for specific uses.
Is Sucralfate oral suspension a controlled substance?
Sucralfate oral suspension is not classified as a controlled substance by the DEA.
What is the generic name for Sucralfate oral suspension?
The generic name for Sucralfate oral suspension is sucralfate. There are 12 other brand versions of sucralfate.
What is the NDC code for Sucralfate oral suspension 1 g/10mL?
The NDC (National Drug Code) for Sucralfate oral suspension 1 g/10mL is 68462-827, listed by Glenmark Pharmaceuticals Inc., USA.